US Edition
Published • loading... • Updated
Teaching the Immune System: Trials Free Liver and Kidney Recipients from Lifelong Anti-Rejection Drugs
Summary by WebProNews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Teaching the Immune System: Trials Free Liver and Kidney Recipients from Lifelong Anti-Rejection Drugs
Every year, tens of thousands receive new organs. Kidneys top the list. Livers follow close. Success rates impress. But lifelong drugs shadow every victory. Immunosuppressants ward off rejection. They also invite infections, cancers, diabetes. Side effects mount over decades. What if recipients could ditch those pills? A fresh trial from Pittsburgh points that way. Three patients stayed drug-free for three years after liver transplants. No rejec…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
